newsfilter
← Latest News
PR Newswire·

Rigel to Present at the 44th Annual J.P. Morgan Healthcare Conference

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced...